UnannouncedVCInvestor

NFX SL Advantage

Startup rounds since 2021 with a NFX SL Advantage investor on the board, and the firm's own fund filings.

Raises
9
since 2021
Unannounced
0
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name

Rounds

  1. TwoStep Therapeutics, Inc.$21.1MUnclear20 Jan 2026 · San Carlos, CA
  2. ImmuneBridge Inc.$5.63MUnclear2 Apr 2025 · San Francisco, CA
  3. Talus Bioscience, Inc.$9.42MFiled before 202512 Aug 2024 · Seattle, WA
  4. TwoStep Therapeutics, Inc.$6.5MFiled before 202518 Mar 2024 · Palo Alto, CA
  5. resistanceBio, Inc.$12.8MFiled before 202531 Jan 2024 · Menlo Park, CA
  6. Pepper Bio, Inc.$3.62MFiled before 202525 Jan 2023 · Dedham, MA
  7. Pepper Bio, Inc.$150KFiled before 202525 Jan 2023 · Dedham, MA
  8. Pepper Bio, Inc.$1MFiled before 202525 Jan 2023 · Dedham, MA
  9. La Jolla Labs Inc$3.5MFiled before 202528 Oct 2021 · La Jolla, CA

By year

YearRaisesUnannounced
202610
202510
20243—
20233—
20211—

Raises are checked for an announcement from 2025 on.

Funds

The firm's own fund filings, each at its latest filing.

FundFiledSizeRaised
NFX SL Advantage I, L.P.3 Mar 2026$14.6M—

Listed because a NFX SL Advantage fund's filing names a director of each company. A name match is not a verified identity.